The results show promising potential for stabilization and healing of fracture-prone bone lesions. The research team envisions sicXer and boXer as components of a novel combined systemic and local ...
The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where ... The results show promising potential for stabilization and healing of fracture-prone bone lesions.
Bimagrumab, a drug originally developed for muscle loss, may help reduce the risk of osteoporosis in weight loss medication ...
The team tackled a critical challenge in treating multiple myeloma—a blood cancer where ... The results show promising potential for stabilization and healing of fracture-prone bone lesions.